Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
This study provides a rationale for testing the lipoprotein(a) lowering hypothesis in cardiovascular disease outcomes trials.FundingNovartis Pharma AG.
Source: The Lancet - Category: General Medicine Source Type: research
More News: Cardiology | Cardiovascular | Cholesterol | Coronary Heart Disease | Diabetes | Endocrinology | General Medicine | Genetics | Heart | Heart Disease | Pharmaceuticals | Smokers | Statin Therapy | Stroke | Study | Women